Cytiva is a biotechnology company based in Umeå, Sweden. It specializes in providing technologies and services that support the development and manufacturing of biopharmaceuticals. The company focuses on areas such as cell culture, purification, and bioprocessing, offering a range of products that facilitate the production of biologics, including vaccines and therapeutic proteins.
As part of its operations, Cytiva emphasizes innovation and collaboration with various stakeholders in the biotechnology sector. The company is involved in advancing scientific research and improving manufacturing processes to enhance the efficiency and effectiveness of biopharmaceutical production. Cytiva's contributions are significant in addressing the growing demand for biologic therapies and in supporting the global healthcare landscape.